All News

Bruton tyrosine kinase (BTK) inhibitors and other new drugs are improving outcomes for patients with CLL.

Regardless of breastfeeding duration, women who did so after giving birth had a lower risk of developing ovarian cancer, including high-grade tumors.

The Food and Drug Administration approved the dual immunotherapy of Opdivo and Yervoy for the treatment of patients with advanced hepatocellular carcinoma. Here’s what you need to know.

For once, I'm noticing a new role of cancer in my life as the survival skills I've picked up are helping me persevere through a global pandemic.

The COVID-19 pandemic has created a unique challenge for patients with myelodysplastic syndromes and acute myeloid leukemia, creating many questions that experts tried to answer in a recent webinar from The Aplastic Anemia and MDS International Foundation.

Patients with mantle cell lymphoma who were eligible for stem cell transplant saw a 97% overall response rate to a three-drug regimen, according to findings from two clinical trials.

If you or someone in your home does contract coronavirus, your doctor may suspend or delay your cancer treatments to protect your immune system, an expert from Tampa Bay Radiation Oncology notes.

The COVID-19 pandemic has brought a number of new challenges to patients with cancer, and one of them is reliving the isolation and anxiety that cancer brings.

At one-year follow-up, phase 2 clinical trial results showed that most patients with relapsed or treatment resistant mantle cell lymphoma responded to chimeric antigen receptor (CAR)-T cell therapy.

The Food and Drug Administration approved the first and only erythroid maturation agent to treat patients with MDS who require red blood cell transfusions and have failed an erythropoiesis stimulating agent.

A survivor talks about leaving the gate open and racing out of it when diagnosed with cancer.

Patient advocacy group Facing Our Risk of Cancer Empowered addressed individuals with hereditary cancer syndromes to offer suggestions for decreasing anxiety and fear during the COVID-19 pandemic.

From an investigational cancer therapy being studied as a treatment for COVID-19 to the NBA and NHL helping to raise over $500,000 for prostate cancer research, here’s what’s making headlines in the cancer space this week.

Two hematologist/oncologists on the LLS leadership team, and experts in the field of blood cancer, answer questions and concerns about coronavirus (COVID-19).

Practicing kindness can help survivors, patients and everyone else get through this pandemic together.

A new study links e-cigarette use to bladder cancer but experts say more research is needed.

As the novel coronavirus outbreak begins impacting many facets of cancer care in the United States, it’s easy to have possibly missed some of the news surrounding COVID-19 and cancer. Here are four things that our readers may have missed.

Help others in need by donating blood where possible!

At the best of times, cancer is a difficult burden to bear, but in the midst of a pandemic, it's especially worse. But patients with cancer know the way out is by going through.

The COVID-19 pandemic's impact is being felt all throughout the cancer community, and experts from the CLL Society hosted a webinar to discuss the specific impacts of the pandemic on patients with chronic lymphocytic leukemia.

Here are the top 5 stories from CURE® for March 2020.

Although the absolute risk for colorectal cancer is very low for young people, one expert warns the incidence is increasing.

One survivor on "New Normals" and living through "apocalyptic" times that reveal who we really are.

Researchers from China examined the impact that coronavirus has on patients who are receiving anti-cancer treatment.

The development of an inpatient symptom monitoring intervention, according to researchers, may enhance awareness of patient symptom burden and improve symptom control and health care usage.

One survivor reflects on how quarantine amid the coronavirus outbreak is impacting her life and reflects on current events.

The Food and Drug Administration approved Imfinzi in combination with certain standard-of-care chemotherapies in extensive-stage small cell lung cancer, as the therapy improves median overall survival.

30 years after cancer treatment, one survivor returns to the Ronald McDonald House that made a major difference in their cancer journey.